CELLS AND METHODS FOR IMPROVED IMMUNOTHERAPY

    公开(公告)号:US20210386784A1

    公开(公告)日:2021-12-16

    申请号:US17412572

    申请日:2021-08-26

    Abstract: Cells comprising an exogenous protein and decreased SH2B adapter protein 3 (SH2B3) protein expression and/or function are provided. Pharmaceutical compositions comprising the cells of the invention as well as methods of treating a disease in a subject in need thereof comprising administering a cell and/or a pharmaceutical composition of the invention, and of determining suitability for treatment, are also provided.

Patent Agency Ranking